Study outcomes. by Jonathan S. Jahr (2709088)

“…A total of 103 subjects were evaluated, of whom 38 received intravenous dexamethasone (either 4 mg, 8 mg, or 10 mg) during their anesthetic course and 65 patients had not received dexamethasone. The average heart rate (HR) slowing (3.2 bpm ± 3.9 in the control group, 3.7 bpm ± 3.8 in the dexamethasone group), and maximal HR slowing (5.0 bpm ± 3.9 in the control group, 5.0 bpm ± 3.8 in the dexamethasone group) over the five minutes following sugammadex administration were not significant between groups (average HR slowing p = 0.553, maximal HR slowing p = 0.988). …”

Patient characteristics. by Jonathan S. Jahr (2709088)

“…A total of 103 subjects were evaluated, of whom 38 received intravenous dexamethasone (either 4 mg, 8 mg, or 10 mg) during their anesthetic course and 65 patients had not received dexamethasone. The average heart rate (HR) slowing (3.2 bpm ± 3.9 in the control group, 3.7 bpm ± 3.8 in the dexamethasone group), and maximal HR slowing (5.0 bpm ± 3.9 in the control group, 5.0 bpm ± 3.8 in the dexamethasone group) over the five minutes following sugammadex administration were not significant between groups (average HR slowing p = 0.553, maximal HR slowing p = 0.988). …”

Molecular Insights on Methane Hydrate Dissociation in the Presence/Absence of Poly-<i>N-</i>vinylcaprolactam: Effects of Gas Saturation and Nanobubbles by Yang Liu (4829)

Subjects:

Molecular Insights on Methane Hydrate Dissociation in the Presence/Absence of Poly-<i>N-</i>vinylcaprolactam: Effects of Gas Saturation and Nanobubbles by Yang Liu (4829)

Subjects:

Molecular Insights on Methane Hydrate Dissociation in the Presence/Absence of Poly-<i>N-</i>vinylcaprolactam: Effects of Gas Saturation and Nanobubbles by Yang Liu (4829)

Subjects:

Age-standardised rates (per 100,000 population) of rheumatoid arthritis burden attributable to smoking in 1990 and 2021, and trends from 1990 to 2021, by GBD Super-Region. by Kaibin Lin (9911049)

Subjects:

Demographic data of female participants (n = 30). by Vanessa Wellauer (18408477)

Subjects:

Results of physiological parameters. by Vanessa Wellauer (18408477)

Subjects:

Results of recovery parameters. by Vanessa Wellauer (18408477)

Subjects:

Raw data used for statistical analysis. by Vanessa Wellauer (18408477)

Subjects:

Schematic representation of the experimental protocol over time. by Vanessa Wellauer (18408477)

Subjects:

Pairwise comparisons of the intervention effects by time point for physiological parameters. by Vanessa Wellauer (18408477)

Subjects:

CONSORT flowchart of participants. by Vanessa Wellauer (18408477)

Subjects:

Pairwise comparisons of the intervention effects by time point for recovery parameter. by Vanessa Wellauer (18408477)

Subjects:

Venn diagram to illustrate the distribution and overlap of significant lipid metabolites across the different comparisons. by Laia Bertran (3685147)

Refractive error, spectacle wear, and referrals among public and private school children based on the AAPOS 2021 referral criteria. by Zahi Wehbi (14863016)

Subjects:

Demographics of all study participants (n = 308 students; 616 eyes). by Zahi Wehbi (14863016)

Subjects:

The sets of referral criteria applied in the study. by Zahi Wehbi (14863016)

Subjects:

Summary of significant treatment × time effect. by Wensheng Xiao (16557866)

Stir casting setup with furnace. by Charles Sarala Rubi (21608723)

Subjects: